Injective Protocol Revenue and Competitors
Estimated Revenue & Valuation
- Injective Protocol's estimated annual revenue is currently $4.7M per year.
- Injective Protocol's estimated revenue per employee is $98,800
- Injective Protocol's total funding is $17.1M.
- Injective Protocol's current valuation is $1B.
Employee Data
- Injective Protocol has 48 Employees.
- Injective Protocol grew their employee count by 26% last year.
Injective Protocol's People
| Name | Title | Email/Phone |
|---|
Injective Protocol Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24M | 154 | 1% | $176M | $1.7B |
#2 | $4.5M | 43 | 39% | N/A | N/A |
What Is Injective Protocol?
Decentralized Derivatives Trading. Any Market. Anytime. Anywhere. \n\nInjective is the first front-running resistant, layer-2 exchange protocol that unlocks the full potential of borderless decentralized finance (DeFi) by supporting margin trading, derivatives, and futures.\n\nInjective is backed by industry titans such as Pantera Capital, Binance, and Hashed.\n\nJoin Us: http://linktr.ee/injective
keywords:Finance, Finance Technology, Cryptocurrency, Blockchains
$17.1M
Total Funding
48
Number of Employees
$4.7M
Revenue (est)
26%
Employee Growth %
$1B
Valuation
N/A
Accelerator
Injective Protocol News
Another major issue that the Injective Protocol helps to reduce is scalability concerns. When a blockchain network experiences congestion, it...
The injective protocol is founded by Injective Labs, a research and development company. It is a fully decentralized layer-2 derivatives...
Injective Protocol (INj) is a decentralized exchange offering advanced features like cross-chain margin trading, derivatives, futures, etc.
New York, NY, Nov. 16, 2021 (GLOBE NEWSWIRE) -- (via Blockchain Wire) Injective Protocol, the first universal DeFi protocol for cross-chain derivatives trading, has announced the successful public launch of its main network alongside a $120 million protocol incentive program named Astro for trad ...
New York, NY, Nov. 16, 2021 (GLOBE NEWSWIRE) -- (via Blockchain Wire) Injective Protocol, the first universal DeFi protocol for cross-chain derivatives trading, has announced the successful public launch of its main network alongside a $120 million protocol incentive program named Astro for trad ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.6M | 48 | 41% | N/A |
#2 | $3.5M | 48 | 9% | N/A |
#3 | $7.9M | 48 | -17% | N/A |
#4 | $7.4M | 48 | 9% | N/A |
#5 | $7.9M | 48 | 7% | N/A |